Cargando…
Intratumor heterogeneity and cell secretome promote chemotherapy resistance and progression of colorectal cancer
The major underlying cause for the high mortality rate in colorectal cancer (CRC) relies on its drug resistance, to which intratumor heterogeneity (ITH) contributes substantially. CRC tumors have been reported to comprise heterogeneous populations of cancer cells that can be grouped into 4 consensus...
Autores principales: | Källberg, Julia, Harrison, Alexandra, March, Valerie, Bērziņa, Santa, Nemazanyy, Ivan, Kepp, Oliver, Kroemer, Guido, Mouillet-Richard, Sophie, Laurent-Puig, Pierre, Taly, Valérie, Xiao, Wenjin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160076/ https://www.ncbi.nlm.nih.gov/pubmed/37142595 http://dx.doi.org/10.1038/s41419-023-05806-z |
Ejemplares similares
-
Technological Advances in Tumor-On-Chip Technology: From Bench to Bedside
por: Bērziņa, Santa, et al.
Publicado: (2021) -
Intratumor CMS Heterogeneity Impacts Patient Prognosis in Localized Colon Cancer
por: Marisa, Laetitia, et al.
Publicado: (2021) -
Downregulation of mitochondrial complex I induces ROS production in colorectal cancer subtypes that differently controls migration
por: Bastin, Jean, et al.
Publicado: (2023) -
Small cell lung cancer responds to immunogenic chemotherapy followed by PD-1 blockade
por: Kroemer, Guido, et al.
Publicado: (2021) -
Everolimus and plicamycin specifically target chemoresistant colorectal cancer cells of the CMS4 subtype
por: Deng, Jiayin, et al.
Publicado: (2021)